Theraclion SA (EPA:ALTHE)
0.4850
-0.0150 (-3.00%)
May 14, 2026, 5:27 PM CET
Theraclion Market Cap
Theraclion has a market cap or net worth of €36.55 million as of May 14, 2026. Its market cap has increased by 229.22% in one year.
Market Cap
36.55M
Enterprise Value
44.41M
Revenue
652.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.49
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 37.53M to 36.55M, a decrease of -2.60%. That is a compound annual growth rate of -0.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 36.55M | 29.24% |
| Dec 31, 2025 | 28.28M | 85.64% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Median Technologies | 183.24M |
| Carvolix | 178.92M |
| Guerbet | 126.03M |
| Novacyt | 57.75M |
| Diagnostic Medical Systems | 34.45M |
| Implanet | 28.42M |
| Biosynex | 24.37M |
| Ikonisys | 22.18M |